UNF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
UniFirst Corp (UNF) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock has shown some positive technical indicators, the lack of significant growth in financial performance, insider selling, and mixed sentiment from analysts and news suggest a cautious approach. The investor should consider holding off on buying until more favorable conditions emerge or clearer growth catalysts are identified.
The technical indicators show mixed signals. The MACD is below 0 and negatively contracting, indicating bearish momentum. The RSI is neutral at 66.871, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at 261.633 and 264.029, with support at 253.874 and 251.478. The stock is trading near resistance, suggesting limited upside in the short term.
The company reported a slight increase in revenue (+3.37% YoY) and gross margin (+2.50% YoY) in Q2
Bullish moving averages indicate a positive long-term trend.
Barclays recently upgraded the stock to Equal Weight with a $250 price target.
Insider selling has increased significantly (41053.61% over the last month), which could indicate a lack of confidence from management.
Net income (-16.25% YoY) and EPS (-13.74% YoY) have declined, reflecting weaker profitability.
News of potential shareholder rights violations related to the company's sale or merger could create uncertainty.
UBS maintains a Neutral rating despite raising the price target to $260, showing limited enthusiasm from analysts.
In Q2 2026, UniFirst's revenue increased by 3.37% YoY to $622.5 million, but net income dropped by 16.25% YoY to $20.48 million. EPS also declined by 13.74% YoY to 1.13. Gross margin improved slightly to 29.47%, up 2.50% YoY. Overall, the financial performance shows modest revenue growth but declining profitability.
Analysts have mixed opinions. UBS raised the price target to $260 but maintained a Neutral rating, while Barclays upgraded the stock to Equal Weight from Underweight with a $250 price target. The sentiment is cautious, with no strong buy recommendations.
